FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057514737> ?p ?o ?g. }

• W2057514737 endingPage "682" @default.
• W2057514737 startingPage "674" @default.
• W2057514737 abstract "Among 810 consecutive hematopoietic stem cell transplantation (HSCT) patients, 679 survived more than 3 months and were evaluated for chronic GVHD. The aim of this study was to find predisposing factors increasing the risk of development of moderate-to-severe chronic GVHD. Many of the donors were HLA-identical siblings or related (n = 435), 185 were HLA-matched unrelated, and 59 were mismatched related or unrelated donors. Most of the patients had a hematological malignancy (n = 568), but 111 patients with a nonmalignant disease were included. Two hundred twenty-three patients (33%) developed mild, 41 (6%) moderate, and 15 (2.2%) severe chronic GVHD. The 5-year probability of development of moderate-to-severe chronic GVHD was 10%. We analyzed 30 potential risk factors for chronic GVHD. In the multivariate analysis, acute GVHD grades II to IV (relative hazard [RH], 2.30; 95% CI, 1.29- 4.10; P = .005), CML diagnosis (RH, 2.37; CI, 1.38-4.08; P = .002) and transplantation from an immunized female donor to a male recipient (RH, 2.16; CI, 1.14-4.11; P = .02) were independent risk factors for moderate-to-severe chronic GVHD. Recipient age also was significant (RH, 2.42; CI, 1.23-4.77; P = .01) if CML was not included in the analysis. In patients with no risk factors, the 5-year probability of development of moderate-to-severe chronic GVHD was 5%. In patients with 1 risk factor, the probability was 13%; 2 risk factors, 23%; and 3 risk factors, 45%. Among patients who developed chronic GVHD (n = 279), acute GVHD grades II to IV (RH, 2.18; CI, 1.23-3.86; P < .01) was the only predictive factor for moderate-to-severe chronic GVHD versus mild disease. Patients with previous acute GVHD grades II to IV may benefit from more aggressive initial treatment. This possibility would have to be examined in clinical trials.Biol Blood Marrow Transplant 2002;8(12):674-82." @default.
• W2057514737 created "2016-06-24" @default.
• W2057514737 creator A5003097876 @default.
• W2057514737 creator A5008700475 @default.
• W2057514737 creator A5012943814 @default.
• W2057514737 creator A5023489502 @default.
• W2057514737 creator A5054924589 @default.
• W2057514737 creator A5065745451 @default.
• W2057514737 creator A5074635260 @default.
• W2057514737 creator A5079082437 @default.
• W2057514737 creator A5080055664 @default.
• W2057514737 date "2002-12-01" @default.
• W2057514737 modified "2023-10-01" @default.
• W2057514737 title "Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation" @default.
• W2057514737 cites W1274344746 @default.
• W2057514737 cites W1504310442 @default.
• W2057514737 cites W1509523292 @default.
• W2057514737 cites W1539774679 @default.
• W2057514737 cites W1562876511 @default.
• W2057514737 cites W1580788756 @default.
• W2057514737 cites W1597544321 @default.
• W2057514737 cites W1666992241 @default.
• W2057514737 cites W181840914 @default.
• W2057514737 cites W1893871329 @default.
• W2057514737 cites W1965979673 @default.
• W2057514737 cites W1972646907 @default.
• W2057514737 cites W1979300931 @default.
• W2057514737 cites W1988804393 @default.
• W2057514737 cites W1995290225 @default.
• W2057514737 cites W2022638963 @default.
• W2057514737 cites W2024145834 @default.
• W2057514737 cites W2025229215 @default.
• W2057514737 cites W2035057483 @default.
• W2057514737 cites W2038252730 @default.
• W2057514737 cites W2051395776 @default.
• W2057514737 cites W2052071946 @default.
• W2057514737 cites W2055201032 @default.
• W2057514737 cites W2056183179 @default.
• W2057514737 cites W2071549635 @default.
• W2057514737 cites W2075683626 @default.
• W2057514737 cites W2082205805 @default.
• W2057514737 cites W2083753204 @default.
• W2057514737 cites W2117194013 @default.
• W2057514737 cites W2136669587 @default.
• W2057514737 cites W2149373622 @default.
• W2057514737 cites W2160808195 @default.
• W2057514737 cites W2249610298 @default.
• W2057514737 cites W2292226371 @default.
• W2057514737 cites W2315559141 @default.
• W2057514737 cites W2337969406 @default.
• W2057514737 cites W2395504431 @default.
• W2057514737 cites W2402976857 @default.
• W2057514737 cites W2403285790 @default.
• W2057514737 cites W2404582537 @default.
• W2057514737 cites W2409397519 @default.
• W2057514737 cites W2410704717 @default.
• W2057514737 cites W2411118847 @default.
• W2057514737 cites W2416303802 @default.
• W2057514737 cites W2462895704 @default.
• W2057514737 cites W2468274911 @default.
• W2057514737 cites W50679872 @default.
• W2057514737 cites W5387557 @default.
• W2057514737 cites W266182593 @default.
• W2057514737 doi "https://doi.org/10.1053/bbmt.2002.v8.abbmt080674" @default.
• W2057514737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12523580" @default.
• W2057514737 hasPublicationYear "2002" @default.
• W2057514737 type Work @default.
• W2057514737 sameAs 2057514737 @default.
• W2057514737 citedByCount "77" @default.
• W2057514737 countsByYear W20575147372012 @default.
• W2057514737 countsByYear W20575147372013 @default.
• W2057514737 countsByYear W20575147372014 @default.
• W2057514737 countsByYear W20575147372015 @default.
• W2057514737 countsByYear W20575147372016 @default.
• W2057514737 countsByYear W20575147372017 @default.
• W2057514737 countsByYear W20575147372018 @default.
• W2057514737 countsByYear W20575147372019 @default.
• W2057514737 countsByYear W20575147372020 @default.
• W2057514737 countsByYear W20575147372022 @default.
• W2057514737 countsByYear W20575147372023 @default.
• W2057514737 crossrefType "journal-article" @default.
• W2057514737 hasAuthorship W2057514737A5003097876 @default.
• W2057514737 hasAuthorship W2057514737A5008700475 @default.
• W2057514737 hasAuthorship W2057514737A5012943814 @default.
• W2057514737 hasAuthorship W2057514737A5023489502 @default.
• W2057514737 hasAuthorship W2057514737A5054924589 @default.
• W2057514737 hasAuthorship W2057514737A5065745451 @default.
• W2057514737 hasAuthorship W2057514737A5074635260 @default.
• W2057514737 hasAuthorship W2057514737A5079082437 @default.
• W2057514737 hasAuthorship W2057514737A5080055664 @default.
• W2057514737 hasBestOaLocation W20575147371 @default.
• W2057514737 hasConcept C126322002 @default.
• W2057514737 hasConcept C203014093 @default.
• W2057514737 hasConcept C207103383 @default.
• W2057514737 hasConcept C2777408962 @default.
• W2057514737 hasConcept C2779134260 @default.
• W2057514737 hasConcept C2779399171 @default.
• W2057514737 hasConcept C2779972918 @default.

• next